This overview highlights mood-related side effects of bupropion (the active ingredient in brand names like Wellbutrin and Zyban) using the most recent FDA-approved labeling and regulatory references. It is not a substitute for the full prescribing information. Patients should review the official FDA label and Medication Guide for comprehensive safety details, including contraindications, interactions, and boxed warnings.
Founder at Anticipate
Updated:
Anticipate is not a medical provider and does not offer medical advice, diagnosis or treatment. The content on this page is informational and should not replace advice from your healthcare professional. Always speak with your clinician about medication questions or changes in mood.
Primary source: FDA Prescribing Information – Wellbutrin XL (Revised 2025)
If you’re looking for the brand-specific version, see: Wellbutrin side effects on mood.
Bupropion hydrochloride is an FDA-approved medication used for major depressive disorder (MDD) and other indications depending on the formulation/brand (for example, Zyban is used for smoking cessation).
According to FDA labeling, bupropion acts on neurotransmitter systems involved in mood, activation, and reward, which is one reason it’s often described as more “activating” than some other antidepressants — an effect that can be helpful for some people and uncomfortable for others.
Bupropion’s activating profile can change how people feel — especially early in treatment or after dose changes. Some people report increased drive or energy, while others experience jitteriness, anxiety, restlessness, irritability, or sleep disruption, which can look and feel like mood instability.
The following information is based on FDA-approved prescribing information (2025 revision) and associated Medication Guide language for bupropion products.
FDA labeling and patient guidance materials commonly include activating/behavioral effects such as:
These are often noticed early in treatment or when the dose is changed.
FDA labeling also emphasizes monitoring for more serious behavioral or mood changes, which may include:
Monitoring is emphasized particularly early in treatment and after dose adjustments.
Bupropion products used as antidepressants carry an FDA boxed warning on suicidal thoughts and behaviors in certain populations (notably children/adolescents/young adults taking antidepressants). The label recommends close observation for worsening depression, unusual behavior changes, agitation/irritability, or emergent suicidal thoughts — especially early in therapy and around dose changes.
In the UK, bupropion is licensed primarily for smoking cessation (commonly as Zyban). UK prescribing references list psychiatric effects such as insomnia, agitation, and anxiety, and patient leaflets include cautions about mental status changes and (in some cases) extreme mood swings, especially in people with prior mental health history.
FDA patient guidance notes that it may take several weeks to feel the medication’s full antidepressant effect, while activating side effects like insomnia or agitation can appear earlier — meaning the “side effects first, benefits later” pattern is a common reason people feel uncertain in the first stretch.
A practical way to think about it (non-prescriptive, monitoring-focused):
Even when bupropion contributes, mood shifts are often amplified by:
FDA labeling emphasizes monitoring for behavioral and mood changes, particularly:
That makes structured tracking useful for observation and for having clearer conversations with clinicians.
Anticipate is not a medical device and does not replace professional care. However, as a mood tracking app, it can support observation by helping users track:
By reviewing patterns over time, users may be better prepared to describe what’s happening to their healthcare provider—especially during the first weeks or after dose changes.
This page is based on publicly available, up-to-date regulatory sources including:
Information is reviewed periodically to reflect the latest official updates.
Scan to download
Scan to download
